About the Job
Foundation Medicine performed over 100,000 next-generation sequencing (NGS) tests in 2022 with volumes expected to increase as more physicians order comprehensive genomic profiling (CGP) -F1CDx, F1LCDx, and F1Heme- testing for their patients. The scale and complexity of this volume of testing and the evolving testing menu requires involvement of Pathology and Diagnostic Medicine in all steps of the process. In particular, it is critical that a board-certified molecular genetic pathologist with training and experience in next-generation sequencing is available during wet lab sequencing, post-pipeline sequence data curation, and variant classification and interpretation to ensure that the results accurately reflect the biology of the patient’s sample and follow CAP/CLIA/NYS/FDA guidelines for the performance of each assay. The role of Director, Molecular Pathology centralizes these responsibilities to one pathologist–supervision of molecular technologists (CAM and RTP); review of wet lab sequencing metrics and troubleshooting (CAM and RTP); supervision of bioinformatics case curation by computational biology operations (CBO) (CAM); ongoing reevaluation and updating of curation SOPs (CAM); ensuring adequate post-pipeline analysis training for members of CBO, TOCR, the MSL team, and pathology (CAM); collaboration with other FMI stakeholders (CAM and RTP); and final release of CGP results to patients and their physicians (CAM and RTP). This supervision will allow FMI to identify problems as they arise and work toward implementing permanent solutions. The Director, Molecular Pathology is a results-oriented medical operations leader, reporting to the Senior Laboratory Director at the local site (CAM or RTP). In addition, this pathologist will also continue to participate in the Diagnostic Medicine service.
This is a regulated position and additional information may be available from QA on the qualifications for this role pertaining to regulatory guidelines.
Foundation Medicine, Inc. (FMI) began with an idea—to simplify the complex nature of cancer genomics, bringing cutting-edge science and technology to everyday cancer care. Our approach generates insights that help doctors match patients to more treatment options and helps accelerate the development of new therapies. Foundation Medicine is the culmination of talented people coming together to realize an important vision, and the work we do every day impacts real lives.
Confidence, or the belief that we need to check every box before applying for a job, can sometimes hold us back from going after a role that inspires us. At Foundation Medicine there's no such thing as the 'perfect' applicant, and our company is a place where every employee can make an impact and continue to grow whatever background they may have or path they may have taken. So, as long as you meet the basic qualifications for a role, please apply if you see a position that would make you excited to come into Foundation Medicine every day and help us transform cancer care.
Internal applicants, please use your FMI email address.
Foundation Medicine is proud to be an Equal Opportunity and Affirmative Action employer and considers all qualified applicants for employment without regard to race, color, religion, sex, gender, sexual orientation, gender identity, ancestry, age, or national origin. Further, qualified applicants will not be discriminated against on the basis of disability or protected veteran status. We also consider qualified applicants regardless of criminal histories, consistent with legal requirements. See also FMI’s EEO Statement and EEO is the Law and Supplement. If you have a disability or special need that requires accommodation, please let us know by completing this form. (EOE/AAP Employer)
To all recruitment agencies: Foundation Medicine does not accept agency resumes. Please do not forward resumes to our jobs alias, Foundation Medicine employees or any other organization location. Foundation Medicine is not responsible for any fees related to unsolicited resumes.